August 2022
aTen Therapeutics awarded £282k Innovate UK grant to develop new breast cancer treatment.
News
News Archive
March 2020
aTen Therapeutics relocates to new offices at 1 Lochrin Square, Fountainbridge, Edinburgh EH3 9QA.
August 2019
Ian Abercrombie appointed Chief Executive Officer at aTen Therapeutics.
July 2019
aTen Therapeutics welcomes Kimberley Meredith on a summer work placement via the University of Edinburgh.
June 2019
aTen Therapeutics attends ‘Outsourcing Clinical Trials’ conference in London.
March 2019
aTen Therapeutics attends Crown Bioscience’s Oncology Drug Discovery Symposium in Cambridge, exploring future approaches to cancer therapies.
February 2019
aTen Therapeutics welcomes Deanna Olubadewo as our new Research Assistant, on a work placement from the University of Edinburgh, via the Santander Universities Scheme.
November 2018
aTen Therapeutics attends the BIA’s 15th Annual bioProcessUK Conference in Edinburgh, “Bioprocess Intensification – Driving down the cost of medicines”.
November 2018
aTen Therapeutics attends the Life Sciences Scotland conference in Glasgow, “Moving forward together: to 2025 and beyond”.
August 2018
aTen Therapeutics has been shortlisted for Corporate LiveWire's Healthcare & Life Sciences Awards 2018, championing the best companies in their respective fields.
May 2018
aTen Therapeutics and IONTAS announce collaboration to discover next-generation antibodies for the treatment of cancer.
May 2018
Francesca Cavallaro joins aTen Therapeutics from the University of Edinburgh to undertake a 3-month work-based MSc project investigating the target of our novel antibody.
May 2018
aTen Therapeutics attends the Scottish Life Sciences awards in Glasgow.
January 2018
Dr Fiona Dempsey (Director of Scientific Operations, aTen Therapeutics) joined Rose Maciewicz from AstraZeneca to address Glasgow University postdocs about industry careers
November 2017
aTen Therapeutics’ Tina Flatau facilitates panel discussion on “Patient Centricity” at Pharma Integrates 2017 in London
November 2017
aTen Therapeutics welcomes Alejandra Rodriguez Sosa MSc (a recent graduate in Drug Design and Biomedical Science) to the team, via the Santander intern scheme
November 2017
aTen Therapeutics attends 14th annual bioProcess UK Conference in Cardiff – “Delivering innovations to patients”
October 2017
aTen Therapeutics signs the Scottish Business Pledge, committing to sustainable growth alongside fairness, equality, opportunity and innovation
September 2017
aTen concurs with the BIA on Brexit: we must stay hand in hand with the EU on medicines regulation, new tariffs should be avoided, speedy recruitment must remain possible and collaborative science/funding mechanisms must continue
September 2017
Anusha Regupathy (MSc pharmaceutical student, Napier University) joins the aTen Therapeutics team, via the Santander Internship Scheme
June 2017
Dr Fiona Dempsey (ex-Cambridge Antibody Technology, Charles River and Heriot-Watt’s Cellular Bioprocessing Group) joins aTen Therapeutics as Director of Scientific Operations
May 2017
aTen Therapeutics attends OBN’s BioTrinity partnering event in London
May 2017
MSc medical biotechnologist Scott Crichton joins aTen as Associate Study Manager
May 2017
aTen joins leading pharmaceutical decision makers at 10th Global Discovery to Innovation Forum
April 2017
aTen Therapeutics attends Sanlam Innovation Investment Conference at Balliol College, Oxford
February 2017
aTen Therapeutics invited to set a challenge for students at Edinburgh University School of Biological Sciences’ Student Industry Meeting
February 2017
October 2016
Antibody specialist Dr Henry Hays joins Oncobiopharm as Scientific Project Manager
May 2016
May 2016
OncoBioPharm Ltd receives £100,000 grant from Scottish Enterprise. Edinburgh, Scotland, 1 May 2016.
February 2016
November 2015
